Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Borbolla, JR; Najera, A; Arana, RM; Lopez-Hernandez, MA; Mendoza, Y; Trueba, E
   In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   J.R. Borbolla et al., "In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients", J HEMATH ST, 10(1), 2001, pp. 19-21
2. Stark, G; O'Brien, SG
   An update on chronic myeloid leukaemia
   CLINICAL MEDICINE
   
   G. Stark e S.G. O'Brien, "An update on chronic myeloid leukaemia", CLIN MED, 1(5), 2001, pp. 354-357
3. Quernin, MH; Duval, M; Litalien, C; Vilmer, E; Aigrain, EJ
   Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry - Application to pharmacokinetic studies in children
   JOURNAL OF CHROMATOGRAPHY B
   
   M.H. Quernin et al., "Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry - Application to pharmacokinetic studies in children", J CHROMAT B, 763(1-2), 2001, pp. 61-69
4. Meirow, D; Nugent, D
   The effects of radiotherapy and chemotherapy on female reproduction
   HUMAN REPRODUCTION UPDATE
   
   D. Meirow e D. Nugent, "The effects of radiotherapy and chemotherapy on female reproduction", HUM REP UPD, 7(6), 2001, pp. 535-543
5. Trisolini, R; Stanzani, M; Agli, LL; Colangelo, A; Bonifazi, F; Falcioni, S; Patelli, M; Falcone, F; Bandini, G; Tura, S; Poletti, V
   Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients
   SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
   
   R. Trisolini et al., "Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients", SARCO VASC, 18(1), 2001, pp. 75-84
6. Li, HC; Kagami, H; Matsui, K; Ono, T
   Restriction of proliferation of primordial germ cells by the irradiation of Japanese quail embryos with soft X-rays
   COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
   
   H.C. Li et al., "Restriction of proliferation of primordial germ cells by the irradiation of Japanese quail embryos with soft X-rays", COMP BIOC A, 130(1), 2001, pp. 133-140
7. Nagahama, T; Sugiura, K; Lee, S; Morita, H; Adachi, Y; Kwon, AH; Kamiyama, Y; Ikehara, S
   A new method for tolerance induction: Busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow
   STEM CELLS
   
   T. Nagahama et al., "A new method for tolerance induction: Busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow", STEM CELLS, 19(5), 2001, pp. 425-435
8. Bilgrami, SFA; Metersky, ML; McNally, D; Naqvi, BH; Kapur, D; Raible, D; Bona, RD; Edwards, RL; Feingold, JM; Clive, JM; Tutschka, PJ
   Idoopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation
   ANNALS OF PHARMACOTHERAPY
   
   S.F.A. Bilgrami et al., "Idoopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation", ANN PHARMAC, 35(2), 2001, pp. 196-201
9. Ritchie, DS; Wirth, A; Grigg, AP
   Successful transplant outcome in a morbidly obese patient with acute myeloblastic leukemia
   LEUKEMIA & LYMPHOMA
   
   D.S. Ritchie et al., "Successful transplant outcome in a morbidly obese patient with acute myeloblastic leukemia", LEUK LYMPH, 42(5), 2001, pp. 1111-1114
10. Beck, JR; Guilhot, J; Giles, FJ; Aoki, N; Wirt, DP; Guilhot, F
    Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia
    LEUKEMIA & LYMPHOMA
    
    J.R. Beck et al., "Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia", LEUK LYMPH, 41(1-2), 2001, pp. 117-124
11. Kokotos, G; Constantinou-Kokotou, V; Padron, JM; Peters, GJ
    Synthesis and in vitro cytotoxicity of novel long chain busulphan analogues
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    G. Kokotos et al., "Synthesis and in vitro cytotoxicity of novel long chain busulphan analogues", BIOORG MED, 11(6), 2001, pp. 861-863
12. Fruehauf, S; Steiger, S; Topaly, J; Ho, AD
    Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia
    ANNALS OF HEMATOLOGY
    
    S. Fruehauf et al., "Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia", ANN HEMATOL, 80(5), 2001, pp. 308-310
13. Hirose, Y; Masaki, Y; Shimoyama, K; Sugai, S; Nojima, T
    Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    Y. Hirose et al., "Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years", EUR J HAEMA, 67(3), 2001, pp. 194-198
14. Kim, I; Park, S; Kim, BK; Chang, HM; Bang, SM; Byun, JH; Kim, DJ; Min, WS; Kim, HJ; Kim, CC
    Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans
    CLINICAL TRANSPLANTATION
    
    I. Kim et al., "Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans", CLIN TRANSP, 15(3), 2001, pp. 167-172
15. Brunstein, CG; McGlave, PB
    The biology and treatment of chronic myelogenous leukemia
    ONCOLOGY-NEW YORK
    
    C.G. Brunstein e P.B. McGlave, "The biology and treatment of chronic myelogenous leukemia", ONCOLOGY-NY, 15(1), 2001, pp. 23
16. Hassan, Z; Hassan, M; Hellstrom-Lindberg, E
    The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro
    LEUKEMIA
    
    Z. Hassan et al., "The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro", LEUKEMIA, 15(8), 2001, pp. 1240-1247
17. Kieffer-Renaux, V; Bulteau, C; Grill, J; Levy-Piebois, C; Couanet, D; Pierre-Kahn, A; Hartmann, O; Kalifa, C
    Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl
    JOURNAL OF CHILD NEUROLOGY
    
    V. Kieffer-Renaux et al., "Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl", J CHILD NEU, 16(9), 2001, pp. 698-704
18. Min, YH; Lee, ST; Kim, JS; Jang, JH; Suh, HC; Kim, HO; Hahn, JS; Ko, YW
    Transplantation of peripheral blood stem cells mobilized by intensified consolidation and granulocyte colony-stimulating factor in acute leukemia
    YONSEI MEDICAL JOURNAL
    
    Y.H. Min et al., "Transplantation of peripheral blood stem cells mobilized by intensified consolidation and granulocyte colony-stimulating factor in acute leukemia", YONSEI MED, 42(1), 2001, pp. 65-73
19. Niiya, H; Kanda, Y; Saito, T; Ohnishi, T; Kanai, S; Kawana, Y; Kamuo, K; Iizuka, A; Yakushijin, K; Ueda, K; Chizuka, A; Iijima, K; Ohnishi, M; Nakai, K; Makimoto, A; Tanosaki, R; Tobinai, K; Wakasugi, H; Takaue, Y; Mineishi, S
    Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan
    HAEMATOLOGICA
    
    H. Niiya et al., "Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan", HAEMATOLOG, 86(10), 2001, pp. 1071-1074
20. Ohnishi, K; Ino, T; Kishimoto, Y; Usui, N; Shimazaki, C; Ohtake, S; Taguchi, H; Kusumoto, S; Kuriyama, K; Hotta, T; Ohno, R
    Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    K. Ohnishi et al., "Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis", CANC CHEMOT, 48, 2001, pp. S59-S64
21. Festing, MFW; Diamanti, P; Turton, JA
    Strain differences in haematological response to chloroamphenicol succinate in mice: implications for toxicological research
    FOOD AND CHEMICAL TOXICOLOGY
    
    M.F.W. Festing et al., "Strain differences in haematological response to chloroamphenicol succinate in mice: implications for toxicological research", FOOD CHEM T, 39(4), 2001, pp. 375-383
22. Balasubramanian, P; Chandy, M; Krishnamoorthy, R; Srivastava, A
    Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    P. Balasubramanian et al., "Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation", BONE MAR TR, 28(9), 2001, pp. 821-825
23. Le Blanc, R; Montminy-Metivier, S; Belanger, R; Busque, L; Fish, D; Roy, DC; Kassis, J; Boileau, J; Lavallee, R; Belanger, D; Letendre, F; Hebert, J; Sauvageau, G; Perreault, C; Roy, J
    Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect
    BONE MARROW TRANSPLANTATION
    
    R. Le Blanc et al., "Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect", BONE MAR TR, 28(9), 2001, pp. 841-848
24. McGuire, TR; Bociek, GR; Pavletic, SZ; Hock, L; Lynch, J; Schneider, J; Hoie, EB; Tarantolo, S; Haire, WD
    Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations
    BONE MARROW TRANSPLANTATION
    
    T.R. McGuire et al., "Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations", BONE MAR TR, 28(9), 2001, pp. 889-893
25. Bleyzac, N; Souillet, G; Magron, P; Janoly, A; Martin, P; Bertrand, Y; Galambrun, C; Dai, Q; Maire, P; Jelliffe, RW; Aulagner, G
    Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
    BONE MARROW TRANSPLANTATION
    
    N. Bleyzac et al., "Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens", BONE MAR TR, 28(8), 2001, pp. 743-751
26. Sandstrom, M; Karlsson, MO; Ljungman, P; Hassan, Z; Jonsson, EN; Nilsson, C; Ringden, O; Oberg, G; Bekassy, A; Hassan, M
    Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients
    BONE MARROW TRANSPLANTATION
    
    M. Sandstrom et al., "Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients", BONE MAR TR, 28(7), 2001, pp. 657-664
27. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
    Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens
    BONE MARROW TRANSPLANTATION
    
    F. Gutierrez-Delgado et al., "Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens", BONE MAR TR, 28(5), 2001, pp. 455-461
28. Meloni, G; Proia, A; Capria, S; Romano, A; Trape, G; Trisolini, SM; Vignetti, M; Mandelli, F
    Obesity and autologous stem cell transplantation in acute myeloid leukemia
    BONE MARROW TRANSPLANTATION
    
    G. Meloni et al., "Obesity and autologous stem cell transplantation in acute myeloid leukemia", BONE MAR TR, 28(4), 2001, pp. 365-367
29. Lucarelli, G; Andreani, M; Angelucci, E
    The cure of the thalassemia with bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    G. Lucarelli et al., "The cure of the thalassemia with bone marrow transplantation", BONE MAR TR, 28, 2001, pp. S11-S13
30. Jacobson, P; Park, JJ; DeFor, TE; Thrall, M; Abel, S; Krivit, W; Peters, C
    Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation
    BONE MARROW TRANSPLANTATION
    
    P. Jacobson et al., "Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation", BONE MAR TR, 27(8), 2001, pp. 855-861
31. Hassan, Z; Ljungman, P; Ringden, O; Winiarski, J; Nilsson, C; Aschan, J; Whitley, HR; Hassan, M
    Pharmacokinetics of liposomal busulphan in man
    BONE MARROW TRANSPLANTATION
    
    Z. Hassan et al., "Pharmacokinetics of liposomal busulphan in man", BONE MAR TR, 27(5), 2001, pp. 479-485
32. Stein, J; Davidovitz, M; Yaniv, I; Ben-Ari, J; Gamzu, Z; Hoffer, E; Bentur, Y; Tabak, A; Krivoy, N
    Accidental busulfan overdose: enhanced drug clearance with hemodialysis ina child with Wiskott-Aldrich syndrome
    BONE MARROW TRANSPLANTATION
    
    J. Stein et al., "Accidental busulfan overdose: enhanced drug clearance with hemodialysis ina child with Wiskott-Aldrich syndrome", BONE MAR TR, 27(5), 2001, pp. 551-553
33. Kroger, N; Zabelina, T; Kruger, W; Renges, H; Stute, N; Kabisch, H; Jaburg, N; Loliger, C; Krull, A; Zander, AR
    Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients
    BONE MARROW TRANSPLANTATION
    
    N. Kroger et al., "Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients", BONE MAR TR, 27(4), 2001, pp. 349-354
34. Copelan, EA; Bechtel, TP; Avalos, BR; Elder, PJ; Ezzone, SA; Scholl, MD; Penza, SL
    Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    E.A. Copelan et al., "Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation", BONE MAR TR, 27(11), 2001, pp. 1121-1124
35. Aich, S; Manna, CK
    Histophysiological changes of the testicular tissue due to busulphan administration in the wild Indian house rat (Rattus rattus)
    ACTA BIOLOGICA HUNGARICA
    
    S. Aich e C.K. Manna, "Histophysiological changes of the testicular tissue due to busulphan administration in the wild Indian house rat (Rattus rattus)", ACT BIOL HU, 52(1), 2001, pp. 105-116
36. Tabak, A; Hoffer, E; Rowe, JM; Krivoy, N
    Monitoring of busulfan area under the curve: Estimation by a single measurement
    THERAPEUTIC DRUG MONITORING
    
    A. Tabak et al., "Monitoring of busulfan area under the curve: Estimation by a single measurement", THER DRUG M, 23(5), 2001, pp. 526-528
37. Milojkovic, D; Mufti, GJ
    Extending the role of allogeneic stem-cell transplantation
    LANCET
    
    D. Milojkovic e G.J. Mufti, "Extending the role of allogeneic stem-cell transplantation", LANCET, 357(9257), 2001, pp. 652-654
38. Kalidas, MT; Kantarjian, H; Talpaz, M
    Chronic myelogenous leukemia
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    M.T. Kalidas et al., "Chronic myelogenous leukemia", J AM MED A, 286(8), 2001, pp. 895-898
39. Poonkuzhali, B; Chandy, M; Srivastava, A; Dennison, D; Krishnamoorthy, R
    Glutathione S-transferase activity influences busulfan pharmacokinetics inpatients with beta thalassemia major undergoing bone marrow transplantation
    DRUG METABOLISM AND DISPOSITION
    
    B. Poonkuzhali et al., "Glutathione S-transferase activity influences busulfan pharmacokinetics inpatients with beta thalassemia major undergoing bone marrow transplantation", DRUG META D, 29(3), 2001, pp. 264-267
40. Appelbaum, FR
    Perspectives on the future of chronic myeloid leukemia treatment
    SEMINARS IN HEMATOLOGY
    
    F.R. Appelbaum, "Perspectives on the future of chronic myeloid leukemia treatment", SEM HEMATOL, 38(3), 2001, pp. 35-42
41. Shinomiya, A; Hamaguchi, S; Shibata, N
    Sexual differentiation of germ cell deficient gonads in the medaka, Oryzias latipes
    JOURNAL OF EXPERIMENTAL ZOOLOGY
    
    A. Shinomiya et al., "Sexual differentiation of germ cell deficient gonads in the medaka, Oryzias latipes", J EXP ZOOL, 290(4), 2001, pp. 402-410
42. Gopal, R; Ha, CS; Tucker, SL; Khouri, IF; Giralt, SA; Gajewski, JL; Andersson, BS; Cox, JD; Champlin, RE
    Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
    CANCER
    
    R. Gopal et al., "Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity", CANCER, 92(7), 2001, pp. 1949-1958
43. Schuler, US; Renner, UD; Kroschinsky, F; Johne, C; Jenke, A; Naumann, R; Bornhauser, M; Deeg, HJ; Ehninger, G
    Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation
    BRITISH JOURNAL OF HAEMATOLOGY
    
    U.S. Schuler et al., "Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation", BR J HAEM, 114(4), 2001, pp. 944-950
44. Jopling, C; Rosendaal, M
    A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan
    BRITISH JOURNAL OF HAEMATOLOGY
    
    C. Jopling e M. Rosendaal, "A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan", BR J HAEM, 113(4), 2001, pp. 970-974
45. Socie, G; Mary, JY; Esperou, H; Robert, DV; Aractingi, S; Ribaud, P; Devergie, A; Toubert, ME; Boudou, P; Cathelinau, B; Gluckman, E; Vexiau, P
    Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation
    BRITISH JOURNAL OF HAEMATOLOGY
    
    G. Socie et al., "Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation", BR J HAEM, 113(1), 2001, pp. 194-201
46. Leung, AYH; Suen, CKM; Lie, AKW; Liang, RHS; Yuen, KY; Kwong, YL
    Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation
    BLOOD
    
    A.Y.H. Leung et al., "Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation", BLOOD, 98(6), 2001, pp. 1971-1978
47. Lee, SJ; Klein, JP; Anasetti, C; Antin, JH; Loberiza, FR; Bowell, BJ; LeMaistre, CF; Litzow, MR; Marks, D; Waller, EK; Matlack, M; Giralt, S; Horowitz, MM
    The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase
    BLOOD
    
    S.J. Lee et al., "The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase", BLOOD, 98(12), 2001, pp. 3205-3211
48. Nichols, WG; Corey, L; Gooley, T; Drew, WL; Miner, R; Huang, ML; Davis, C; Boeckh, M
    Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes
    BLOOD
    
    W.G. Nichols et al., "Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes", BLOOD, 97(4), 2001, pp. 867-874
49. Fukumoto, M; Kubo, H; Ogamo, A
    Quantitative determination of busulfan in serum using gas chromatography -Mass spectrometry in negative-ion chemical ionization mode
    ANALYTICAL LETTERS
    
    M. Fukumoto et al., "Quantitative determination of busulfan in serum using gas chromatography -Mass spectrometry in negative-ion chemical ionization mode", ANAL LETTER, 34(5), 2001, pp. 761-771
50. Davies, SM; DeFor, TE; McGlave, PB; Miller, JS; Verfaillie, CM; Wagner, JE; Weisdorf, DJ
    Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors
    AMERICAN JOURNAL OF MEDICINE
    
    S.M. Davies et al., "Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors", AM J MED, 110(5), 2001, pp. 339-346
51. Schwartz, JM; Wolford, JL; Thornquist, MD; Hockenbery, DM; Murakami, CS; Drennan, F; Hinds, M; Strasser, SI; Lopez-Cubero, SO; Brar, HS; Ko, CW; Saunders, MD; Okolo, CN; McDonald, GB
    Severe gastrointestinal bleeding after hematopoietic cell transplantation,1987-1997: Incidence, causes, and outcome
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    J.M. Schwartz et al., "Severe gastrointestinal bleeding after hematopoietic cell transplantation,1987-1997: Incidence, causes, and outcome", AM J GASTRO, 96(2), 2001, pp. 385-393
52. Barta, A; Denes, R; Masszi, T; Remenyi, P; Batai, A; Torbagyi, E; Sipos, A; Lengyel, L; Jakab, K; Gyodi, E; Reti, M; Foldi, J; Paldi-Haris, P; Avalos, M; Paloczi, K; Fekete, S; Torok, J; Hoffer, I; Jakab, J; Varadi, G; Kelemen, E; Petranyi, G
    Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia
    ACTA HAEMATOLOGICA
    
    A. Barta et al., "Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia", ACT HAEMAT, 105(2), 2001, pp. 64-70
53. Bleyzac, N; Barou, P; Aulagner, G
    Rapid and sensitive high-performance liquid chromatographic method, for busulfan assay in plasma
    JOURNAL OF CHROMATOGRAPHY B
    
    N. Bleyzac et al., "Rapid and sensitive high-performance liquid chromatographic method, for busulfan assay in plasma", J CHROMAT B, 742(2), 2000, pp. 427-432
54. Andersson, BS; Madden, T; Tran, HT; Hu, WW; Blume, KG; Chow, DSL; Champlin, RE; Vaughan, WP
    Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    B.S. Andersson et al., "Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study", BIOL BLOOD, 6(5A), 2000, pp. 548-554
55. Openshaw, H; Lund, BT; Kashyap, A; Atkinson, R; Sniecinski, I; Weiner, LP; Forman, S
    Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    H. Openshaw et al., "Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring", BIOL BLOOD, 6(5A), 2000, pp. 563-575
56. Rodriguez, J; Cortes, J; Talpaz, M; O'Brien, S; Smith, TL; Rios, MB; Kantarjian, H
    Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia
    CLINICAL CANCER RESEARCH
    
    J. Rodriguez et al., "Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia", CLIN CANC R, 6(1), 2000, pp. 147-152
57. Nagarajan, R; Peters, C; Orchard, P; Rydholm, N
    Report of severe neurotoxicity with cyclophosphamide
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    R. Nagarajan et al., "Report of severe neurotoxicity with cyclophosphamide", J PED H ONC, 22(6), 2000, pp. 544-546
58. Mentzer, WC
    Bone marrow transplantation for hemoglobinopathies
    CURRENT OPINION IN HEMATOLOGY
    
    W.C. Mentzer, "Bone marrow transplantation for hemoglobinopathies", CURR OPIN H, 7(2), 2000, pp. 95-100
59. Kami, M; Matsumura, T; Tanaka, Y; Mikami, Y; Miyakoshi, S; Ueyama, J; Morinaga, S; Mori, S; Machida, U; Kanda, Y; Chiba, S; Sakamaki, H; Hirai, H; Muto, Y
    Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: A true marker of acute graft-versus-host disease
    LEUKEMIA & LYMPHOMA
    
    M. Kami et al., "Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: A true marker of acute graft-versus-host disease", LEUK LYMPH, 38(5-6), 2000, pp. 533-540
60. Ikeda, H; Tsuchida, Y; Wu, JG; Suzuki, N; Kuroiwa, M; Choi, SH; Morikawa, A
    Antitumor effects of fotemustine and busulfan against a human neuroblastoma xenograft
    ONCOLOGY REPORTS
    
    H. Ikeda et al., "Antitumor effects of fotemustine and busulfan against a human neuroblastoma xenograft", ONCOL REP, 7(6), 2000, pp. 1265-1268
61. Ohnishi, K; Minami, S; Ueda, T; Nishimura, M; Tsubaki, K; Takemoto, Y; Takeshita, A; Sao, H; Kageyama, S; Ueda, R; Ohno, R
    Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    K. Ohnishi et al., "Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia", INT J HEMAT, 72(2), 2000, pp. 229-236
62. Carreras, E
    Veno-occlusive disease of the liver after hemopoietic cell transplantation
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    E. Carreras, "Veno-occlusive disease of the liver after hemopoietic cell transplantation", EUR J HAEMA, 64(5), 2000, pp. 281-291
63. Peters, WP; Baynes, RB; Cassells, L; Dansey, R; Klein, J; Hamm, C; Karanes, C; Abella, S
    The Dix/Geller article reviewed
    ONCOLOGY-NEW YORK
    
    W.P. Peters et al., "The Dix/Geller article reviewed", ONCOLOGY-NY, 14(2), 2000, pp. 191-192
64. Talpaz, M; Berman, E; Clift, RA; Copelan, EA; Emanuel, PD; Erba, HP; Glenn, MJ; Greenberg, PL; Jones, RJ; O'Brien, S; Saba, HI; Schilder, R; Snyder, DS; Soiffer, RJ; Tallman, MS; Wetzler, M; Ravandi-Kashani, F; Kantarjian, H; Talpaz, M
    NCCN Practice Guidelines for chronic myelogenous leukemia
    ONCOLOGY-NEW YORK
    
    M. Talpaz et al., "NCCN Practice Guidelines for chronic myelogenous leukemia", ONCOLOGY-NY, 14(11A), 2000, pp. 229-240
65. Matsuzaki, A; Eguchi, H; Ikuno, Y; Ayukawa, H; Yanai, F; Ishii, E; Sugimoto, T; Inada, H; Anami, K; Nibu, K; Hara, T; Miyazaki, S; Okamura, J
    Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: A report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan
    PEDIATRIC HEMATOLOGY AND ONCOLOGY
    
    A. Matsuzaki et al., "Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: A report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan", PED HEM ONC, 17(8), 2000, pp. 623-634
66. Arvidson, J; Lonnerholm, G; Tuvemo, T; Carlson, K; Lannering, B; Lonnerholm, T
    Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation
    PEDIATRIC HEMATOLOGY AND ONCOLOGY
    
    J. Arvidson et al., "Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation", PED HEM ONC, 17(4), 2000, pp. 285-297
67. Hehlmann, R
    Trial of IFN or STl571 before proceeding to allografting for CML?
    LEUKEMIA
    
    R. Hehlmann, "Trial of IFN or STl571 before proceeding to allografting for CML?", LEUKEMIA, 14(9), 2000, pp. 1560-1562
68. Tosi, P; Zamagni, E; Ronconi, S; Benni, M; Motta, MR; Rizzi, S; Tura, S; Cavo, M
    Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
    LEUKEMIA
    
    P. Tosi et al., "Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure", LEUKEMIA, 14(7), 2000, pp. 1310-1313
69. Appelbaum, FR
    Is there a best transplant conditioning regimen for acute myeloid leukemia?
    LEUKEMIA
    
    F.R. Appelbaum, "Is there a best transplant conditioning regimen for acute myeloid leukemia?", LEUKEMIA, 14(3), 2000, pp. 497-501
70. Mengarelli, A; Iori, AP; Guglielmi, C; Perrone, MP; Gozzer, M; Girmenia, C; Cimino, G; Testi, AM; Ricci, R; De Felice, L; Girelli, G; Mandelli, F; Arcese, W
    Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies
    LEUKEMIA
    
    A. Mengarelli et al., "Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies", LEUKEMIA, 14(12), 2000, pp. 2052-2058
71. Olavarria, E; Hassan, M; Eades, A; Nilsson, C; Timms, A; Matthews, J; Craddock, C; Kanfer, E; Apperley, J; Goldman, J
    A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation
    LEUKEMIA
    
    E. Olavarria et al., "A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation", LEUKEMIA, 14(11), 2000, pp. 1954-1959
72. Granados, E; de la Camara, R; Madero, L; Diaz, MA; Martin-Regueira, P; Steegmann, JL; Arranz, R; Figuera, A; Fernandez-Ranada, JM
    Hematopoietic cell transplantation in acute lymphoblastic leukemia: betterlong-term event-free survival with conditioning regimens containing total body irradiation
    HAEMATOLOGICA
    
    E. Granados et al., "Hematopoietic cell transplantation in acute lymphoblastic leukemia: betterlong-term event-free survival with conditioning regimens containing total body irradiation", HAEMATOLOG, 85(10), 2000, pp. 1060-1067
73. Tribalto, M; Amadori, S; Cudillo, L; Caravita, T; Del Poeta, G; Meloni, G; Avvisati, G; Petrucci, MT; Pulsoni, A; Leone, G; Sica, S; Martelli, M; Tabilio, A; Fioritoni, G; Majolino, I; Mandelli, F
    Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study
    HAEMATOLOGICA
    
    M. Tribalto et al., "Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study", HAEMATOLOG, 85(1), 2000, pp. 52-58
74. Ohashi, K; Tanabe, J; Watanabe, R; Tanaka, T; Sakamaki, H; Maruta, A; Okamoto, S; Aotsuka, N; Saito, K; Nishimura, M; Oh, H; Matsuzaki, M; Takahashi, S; Yonekura, S
    The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation
    AMERICAN JOURNAL OF HEMATOLOGY
    
    K. Ohashi et al., "The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation", AM J HEMAT, 64(1), 2000, pp. 32-38
75. Peinemann, F; de Villiers, EM; Doorries, K; Adams, O; Vogeli, TA; Burdach, S
    Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bonemarrow transplants
    EUROPEAN JOURNAL OF PEDIATRICS
    
    F. Peinemann et al., "Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bonemarrow transplants", EUR J PED, 159(3), 2000, pp. 182-188
76. McCune, JS; Gibbs, JP; Slattery, JT
    Plasma concentration monitoring of busulfan - Does it improve clinical outcome?
    CLINICAL PHARMACOKINETICS
    
    J.S. McCune et al., "Plasma concentration monitoring of busulfan - Does it improve clinical outcome?", CLIN PHARMA, 39(2), 2000, pp. 155-165
77. Turton, JA; Havard, AC; Robinson, S; Holt, DE; Andrews, CM; Fagg, R; Williams, TC
    An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse
    FOOD AND CHEMICAL TOXICOLOGY
    
    J.A. Turton et al., "An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse", FOOD CHEM T, 38(10), 2000, pp. 925-938
78. Nash, RA
    Prospects of stem cell transplantation in autoimmune diseases
    JOURNAL OF CLINICAL IMMUNOLOGY
    
    R.A. Nash, "Prospects of stem cell transplantation in autoimmune diseases", J CLIN IMM, 20(1), 2000, pp. 38-45
79. Kroger, N; Zabelina, T; Sonnenberg, S; Kruger, W; Renges, H; Stute, N; Finkenstein, F; Mayer, U; Holstein, K; Fiedler, W; Colberg, H; Sonnen, R; Kuse, R; Braumann, D; Metzner, B; del Valle, F; Erttmann, R; Kabisch, H; Zander, AR
    Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia
    BONE MARROW TRANSPLANTATION
    
    N. Kroger et al., "Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia", BONE MAR TR, 26(7), 2000, pp. 711-716
80. Baker, KS; Bostrom, B; DeFor, T; Ramsay, NKC; Woods, WG; Blazar, BR
    Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia
    BONE MARROW TRANSPLANTATION
    
    K.S. Baker et al., "Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia", BONE MAR TR, 26(6), 2000, pp. 607-614
81. Lafay-Cousin, L; Hartmann, O; Plouvier, P; Mechinaud, F; Boutard, P; Oberlin, O
    High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study
    BONE MARROW TRANSPLANTATION
    
    L. Lafay-Cousin et al., "High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study", BONE MAR TR, 26(6), 2000, pp. 627-632
82. Tran, HT; Madden, T; Petropoulos, D; Worth, LL; Felix, EA; Sprigg-Saenz, HA; Choroszy, M; Danielson, M; Przepiorka, D; Chan, KW
    Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies
    BONE MARROW TRANSPLANTATION
    
    H.T. Tran et al., "Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies", BONE MAR TR, 26(5), 2000, pp. 463-470
83. Yeager, AM; Uhas, KA; Coles, CD; Davis, PC; Krause, WL; Moser, HW
    Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)
    BONE MARROW TRANSPLANTATION
    
    A.M. Yeager et al., "Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)", BONE MAR TR, 26(3), 2000, pp. 357-363
84. Lee, KH; Lee, JH; Kim, S; Lee, JS; Kim, SH; Kim, WK
    High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    K.H. Lee et al., "High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation", BONE MAR TR, 26(2), 2000, pp. 147-152
85. Lamparelli, T; van Lint, MT; Gualandi, F; Raiola, AM; Barbanti, M; Sacchi, N; Ficai, G; Ghinatti, C; Bregante, S; Berisso, G; Dominietto, A; Di Grazia, C; Bruno, B; Sessarego, M; Casarino, L; Verdiani, S; Bacigalupo, A
    Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin
    BONE MARROW TRANSPLANTATION
    
    T. Lamparelli et al., "Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin", BONE MAR TR, 26(12), 2000, pp. 1305-1311
86. Dupuis, LL; Najdova, M; Saunders, EF
    Retrospective appraisal of busulfan dose adjustment in children
    BONE MARROW TRANSPLANTATION
    
    L.L. Dupuis et al., "Retrospective appraisal of busulfan dose adjustment in children", BONE MAR TR, 26(11), 2000, pp. 1143-1147
87. Biagi, E; Rovelli, A; Balduzzi, A; De Lorenzo, P; Tagliabue, A; Uderzo, C
    TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission
    BONE MARROW TRANSPLANTATION
    
    E. Biagi et al., "TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission", BONE MAR TR, 26(11), 2000, pp. 1260-1262
88. Grigg, AP; McLachlan, R; Zajac, J; Szer, J
    Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)
    BONE MARROW TRANSPLANTATION
    
    A.P. Grigg et al., "Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)", BONE MAR TR, 26(10), 2000, pp. 1089-1095
89. Gutierrez-Delgado, F; Holmberg, LA; Hooper, H; Appelbaum, FR; Livingston, RB; Maziarz, RT; Weiden, P; Rivkin, S; Montgomery, P; Kawahara, K; Bensinger, W
    High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer
    BONE MARROW TRANSPLANTATION
    
    F. Gutierrez-Delgado et al., "High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer", BONE MAR TR, 26(1), 2000, pp. 51-59
90. Bolinger, AM; Zangwill, AB; Slattery, JT; Glidden, D; DeSantes, K; Heyn, L; Risler, LJ; Bostrom, B; Cowan, MJ
    An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease
    BONE MARROW TRANSPLANTATION
    
    A.M. Bolinger et al., "An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease", BONE MAR TR, 25(9), 2000, pp. 925-930
91. Valteau-Couanet, D; Benhamou, E; Vassal, G; Stambouli, F; Lapierre, V; Couanet, D; Lumbroso, J; Hartmann, O
    Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma
    BONE MARROW TRANSPLANTATION
    
    D. Valteau-Couanet et al., "Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma", BONE MAR TR, 25(9), 2000, pp. 937-942
92. Brockstein, BE; Smiley, C; Al-Sadir, J; Williams, SF
    Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors
    BONE MARROW TRANSPLANTATION
    
    B.E. Brockstein et al., "Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors", BONE MAR TR, 25(8), 2000, pp. 885-894
93. Demirer, T; Ilhan, O; Mandel, NM; Arat, M; Gunel, N; Celebi, H; Ustun, C; Akan, H; Demirer, S; Aydintug, S; Uysal, A; Koc, H
    A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
    BONE MARROW TRANSPLANTATION
    
    T. Demirer et al., "A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies", BONE MAR TR, 25(7), 2000, pp. 697-703
94. Duerst, RE; Horan, JT; Liesveld, JL; Abboud, CN; Zwetsch, LM; Senf, ES; Constine, LS; Raubertas, RF; Passarell, JA; DiPersio, JF
    Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide
    BONE MARROW TRANSPLANTATION
    
    R.E. Duerst et al., "Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide", BONE MAR TR, 25(5), 2000, pp. 489-494
95. Ullery, LL; Gibbs, JP; Ames, GW; Senecal, FM; Slattery, JT
    Busulfan clearance in renal failure and hemodialysis
    BONE MARROW TRANSPLANTATION
    
    L.L. Ullery et al., "Busulfan clearance in renal failure and hemodialysis", BONE MAR TR, 25(2), 2000, pp. 201-203
96. Copelan, EA; Penza, SL; Pohlman, B; Avalos, BR; Goormastic, M; Andresen, SW; Kalaycio, M; Bechtel, TP; Scholl, MD; Elder, PJ; Ezzone, SA; O'Donnell, LC; Tighe, MB; Risley, GL; Young, DC; Bolwell, BJ
    Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
    BONE MARROW TRANSPLANTATION
    
    E.A. Copelan et al., "Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma", BONE MAR TR, 25(12), 2000, pp. 1243-1248
97. Reiffers, J; Labopin, M; Sanz, M; Korbling, M; Blaise, D; De la Rubia, J; Gorin, NC
    Autologous blood cell vs marrow transplantation for acute myeloid leukemiain complete remission: an EBMT retrospective analysis
    BONE MARROW TRANSPLANTATION
    
    J. Reiffers et al., "Autologous blood cell vs marrow transplantation for acute myeloid leukemiain complete remission: an EBMT retrospective analysis", BONE MAR TR, 25(11), 2000, pp. 1115-1119
98. Ahmed, T; Kancherla, R; Qureshi, Z; Mittelman, A; Seiter, K; Mannancheril, A; Puccio, C; Chun, HG; Bar, M; Lipshutz, M; Ali, MF; Goldberg, R; Preti, R; Lake, D; Durrani, H; Farley, T
    High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34(+) selection to clinical outcome
    BONE MARROW TRANSPLANTATION
    
    T. Ahmed et al., "High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34(+) selection to clinical outcome", BONE MAR TR, 25(10), 2000, pp. 1041-1045
99. Afify, Z; Shaw, PJ; Clavano-Harding, A; Cowell, CT
    Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide
    BONE MARROW TRANSPLANTATION
    
    Z. Afify et al., "Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide", BONE MAR TR, 25(10), 2000, pp. 1087-1092
100. Andersson, BS; Gajewski, J; Donato, M; Giralt, S; Gian, V; Wingard, J; Tarantolo, S; Fernandez, H; Hu, WW; Blume, K; Kashyap, A; Forman, SJ; Champlin, RE
     Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
     BONE MARROW TRANSPLANTATION
     
     B.S. Andersson et al., "Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)", BONE MAR TR, 25, 2000, pp. S35-S38